APA (7th ed.) Citation

Al-Qahtani, M. H., Assidi, M., Buhmeida, A., Almuhammadi, A., Pushparaj, P. N., & Alganmi, N. A. (2026). Precision screening identifies mitoxantrone as a multitarget inhibitor in ageing-associated cancers with extensive computational validation and doxorubicin comparison. PLoS ONE, 21(2), 1. https://doi.org/10.1371/journal.pone.0341446

Chicago Style (17th ed.) Citation

Al-Qahtani, Mohammed H., Mourad Assidi, Abdelbaset Buhmeida, Asma Almuhammadi, Peter Natesan Pushparaj, and Nofe Ateq Alganmi. "Precision Screening Identifies Mitoxantrone as a Multitarget Inhibitor in Ageing-associated Cancers with Extensive Computational Validation and Doxorubicin Comparison." PLoS ONE 21, no. 2 (2026): 1. https://doi.org/10.1371/journal.pone.0341446.

MLA (9th ed.) Citation

Al-Qahtani, Mohammed H., et al. "Precision Screening Identifies Mitoxantrone as a Multitarget Inhibitor in Ageing-associated Cancers with Extensive Computational Validation and Doxorubicin Comparison." PLoS ONE, vol. 21, no. 2, 2026, p. 1, https://doi.org/10.1371/journal.pone.0341446.